Long-term effect of molsidomine, a direct nitric oxide donor, as an add-on treatment, on endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: Results of the MEDCOR trial.
2015
The MEDCOR trial is a double-blind, randomized study aiming at demonstrating the superiority of
molsidomine(direct NO donor) over placebo, used as add-on treatments, on improving endothelial function (EF) after 12 months, in stable angina patients undergoing
percutaneous coronary intervention.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
20
References
10
Citations
NaN
KQI